Company intelligence / Profile preview

Taimei Technology

Jiaxing, Zhejiang, Chinataimei.com ↗

Ownership: Private
Employees: ~783
Development stage: Other

Overview

As of March 31, 2024 the company had served over 1,400 pharmaceutical companies and CROs—including most of the top global pharma companies—and more than 40 software products/digital services were in use across China’s life science sector. It holds a leading market share in China for digital solutions supporting pharmaceutical/medical device R&D and commercialization.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Over 1,400 pharmaceutical companies/CROs including partnerships with “21 out of the top 25 global pharmaceutical companies” and “90 of the top 100 Chinese pharma innovators” as clients or partners

Beyond the preview

Go deeper on Taimei Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taimei Technology.

Explore the full profile